APAC
Rising chronic illness drives point of care testing market to $31b mark
Rising chronic illness drives point of care testing market to $31b mark
Asia Pacific is poised to see the strongest expansion.
1 day ago
Rising radiation safety demand to drive medical detection market to $2.22b
Hospitals accounted for 71.7% of the market in 2025.
5 days ago
Ageing, chronic diseases push APAC medtech towards $132b by 2030
Despite this, few companies in the region have scaled globally.
DNA diagnostics market to reach $24.7b by 2034 on precision medicine, genomic advancements
Asia-Pacific emerges as a key growth region.
Asia-Pacific nations roll out WHO framework on air, health risks
Eleven governments launched WHO-backed efforts to strengthen health-based policymaking.
How can healthcare providers make AI pay off?
Most organisations are still breaking even on technology spending.
Label identification technologies market to reach $2.87b by 2031
Asia Pacific is expected to be the fastest-growing regional market.
Hospital demand and AI drive $10b expansion in MRI market in 2036
Hospitals are investing in AI reconstruction to improve scanner utilisation.
Body fluid analysis market to hit $3.65b on neurological and cancer demand
Speciality diagnostics widen across multiple body fluid categories in hospital laboratories.
Global diabetes trials market to double to $10b by 2034
AI-enabled decentralised clinical trials are forecast to grow at a 10.5% CAGR.
Global dialysis market to hit $141.5b by 2031
Asia Pacific is set to register the highest regional CAGR.
How can Asia-Pacific prove medical research is worth the money?
Study finds inconsistent methods can distort funding decisions.
APAC turns to AI as healthcare worker shortfall nears 11 million
Medical inflation nearing 12% in 2025 pushes hospitals toward digital tools.
Medical inflation rises to 11.3% as employers face cost squeeze
One-third of regional markets posted lower healthcare price trends.
How far can institutional capital shape digital health innovation?
Scale increasingly depends less on venture capital backing.
AI moves from pilot phase to core pharma operations
Clinical trials and recruitment are key AI growth areas.
Surgical devices market to surpass $287b by 2031 amidst AI, robotics growth
Increasing use of imaging, analytics, and remote surgical support
Most Read
1. IHH Singapore goes preventive with new Healthspan programme 2. Health ministry unveils homegrown AI model built for patients 3. Indonesia bets on stem cell rules to boost longevity care 4. Australia funds $10.4m RNA lung therapy trials at Monash 5. AI in pharma market to hit $28.6b by 2034 on drug discovery pushResource Center
Read Here
Advertise
Sign Up
Partner Events
Event News
Demand was strong for AI-driven and digital healthcare solutions.
Commentary
AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings
Beyond symptom control: Redefining IMID care in Malaysia
How decentralised clinical trials can unlock Asia's research potential